Oryzon Genomics SA (ORY) — Cash Flow Reinvestment Rate
Oryzon Genomics SA (ORY) has a Cash Flow Reinvestment Rate of 0.17x as of December 2015, reinvesting €87.70K (capex €87.70K ) from operating cash flow of €523.10K. Explore Oryzon Genomics SA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oryzon Genomics SA Cash Flow Reinvestment Rate (2013–2015)
Historical reinvestment intensity for Oryzon Genomics SA across 3 annual periods. Also explore balance sheet size of Oryzon Genomics SA for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oryzon Genomics SA (2013–2015)
Year-by-year capital reinvestment analysis for Oryzon Genomics SA. For live market cap and broader valuation context, see Oryzon Genomics SA (ORY) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 6.74x | €3.53 Million | €523.14K | €87.65K | ▲ +2244.9% |
| 2014 | 0.29x | €3.49 Million | €12.13 Million | €47.00K | ▼ 0.0% |
| 2013 | 0.29x | €3.49 Million | €12.13 Million | €47.30K | — |